logo
CanyamAI summaries for academic research
language
MobileMobile
  • Phone FeatureWeChat Mini Program
EnglishEnglish
noticeNotice
BlogBlog
delete
arrow
BackJournal Details
Lancet Haematology cover

Lancet Haematology

IF17.7
Papers1272
Citations7818
Journal Papers 1837
Publication Date
delete
Thalassaemia revisited: whose progress?
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deletenull The Lancet Haematology
deleteShare
deleteSave
Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteHanny Al-Samkari; Fouzia Aboobacker; Biree Andemariam; Perla Eleftheriou; Hatoon Ezzat; Dimitrios Farmakis; Shahrukh Hashmi; Shruti Kakkar; Aurelio Maggio; Antonio Piga; Alok Srivastava; Mohamed A Yassin; Hasan Abbas Zaheer; Vip Viprakasit; Khaled M Musallam
deleteShare
deleteSave
α-thalassaemia: an overlooked disease entering a new era
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteRafaella Origa; Ashutosh Lal; Thomas D Coates
deleteShare
deleteSave
From pain to purpose: my thalassaemia journey
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteShaluka Hiran Premachandra
deleteShare
deleteSave
MK-4002, a B-cell maturation antigen-targeting T-cell engager, in relapsed or refractory multiple myeloma: a first-in-human, open-label, phase 1 study
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteSumit Madan; Caitlin Costello; Brea Lipe; Andrew J Cowan; Eva Medvedova; Jens Hillengass; P Leif Bergsagel; Xavier Leleu; Cyrille Touzeau; Daniel Morillo; Albert Oriol; Raya Mawad; Henning Schade; Yifah Yaron; Patrick P Ng; Banmeet Anand; Razia Akhtar; Al-Ola Abdallah
deleteShare
deleteSave
Rethinking the possibilities of adult ring sideroblastic anaemia
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteSophie G Carlson; Matthew Koo; Sunil Dommaraju; Alexander H Song; Wanxing Chai-Ho
deleteShare
deleteSave
From survival to self-determination: the chronic warrior
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteKostas Tsourlis
deleteShare
deleteSave
Bridging the thalassaemia divide in south and southeast Asia
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteBingwen Eugene Fan; Anuja Premawardhena
deleteShare
deleteSave
Rethinking anti-BCMA T-cell engager design
deleteLancet Haematology
IF17.7
delete2026-10-06
delete0
PREAI
deleteHolly Lee
deleteShare
deleteSave
Personalising AML treatment: beyond age and fitness
deleteLancet Haematology
IF17.7
delete2026-10-01
delete0
PREAI
deletenull The Lancet Haematology
deleteShare
deleteSave
At the heart of unmet need: TP53 myeloid neoplasms
deleteLancet Haematology
IF17.7
delete2026-10-01
delete0
PREAI
deleteRami S Komrokji; David A Sallman
deleteShare
deleteSave
Clinical activity and safety of rilzabrutinib in patients with previously treated immune thrombocytopenia (LUNA3): results from the open-label period of a phase 3 trial
deleteLancet Haematology
IF17.7
delete2026-09-17
delete0
PREAI
deleteDavid J Kuter; Waleed Ghanima; Nichola Cooper; Howard A Liebman; Lei Zhang; Yu Hu; Yoshitaka Miyakawa; Marie Luise Hütter-Krönke; Cristina Pascual-Izquierdo; Elisa Lucchini; Sylvain Audia; Matias Cordoba; Heidi Krenz; Mengjie Yao; Ahmed Daak
deleteShare
deleteSave
Topical ruxolitinib for chronic cutaneous graft-versus-host disease: a single-centre, randomised, double-blind, intra-patient-controlled phase 2 trial
deleteLancet Haematology
IF17.7
delete2026-09-16
delete0
deleteOAAI
deleteAlina Markova; Jelena Ostojić; Veronica Rotemberg; Ian Nykaza; Jad Kanbar; Esperanza B Papadopoulos; Stephen Dusza; Rizi Ai; Tara Maier; Mario E Lacouture; Roni Tamari; Brian C Shaffer; Michael Scordo; Miguel-Angel Perales; Andrew Harris; Doris M Ponce
deleteShare
deleteSave
Response-adapted inotuzumab ozogamicin in paediatric first-relapse B-cell acute lymphoblastic leukaemia – Authors' reply
deleteLancet Haematology
IF17.7
delete2026-09-09
delete0
PREAI
deleteNicolò Peccatori; Christian Michel Zwaan; Erica Brivio
deleteShare
deleteSave
High time for risk-adapted treatment in mantle cell lymphoma
deleteLancet Haematology
IF17.7
delete2026-09-02
delete0
PREAI
deleteIngrid Glimelius; Anna Nikkarinen; Leo Meriranta; Simon Husby; Christiane Pott
deleteShare
deleteSave
Epcoritamab with rituximab and lenalidomide as first-line treatment for follicular lymphoma (EPCORE NHL-2): an open-label, multicentre, phase 1/2 b trial
deleteLancet Haematology
IF17.7
delete2026-08-27
delete0
deleteOAAI
deleteLorenzo Falchi; Joost S P Vermaat; Joshua D Brody; Lori Leslie; Fritz Offner; Jacob Haaber Christensen; Marcel Nijland; David Belada; Björn Engelbrekt Wahlin; Kristina Drott; Pilar Gomez Prieto; Kateřina Kopečkova; Alejandro Martín García-Sancho; Jian P Mei; Işıl Altıntaş; Malene Risum; Aidan Reilly; Jun Zou; Pau Abrisqueta
deleteShare
deleteSave
Beyond maximum grade: making toxicity count
deleteLancet Haematology
IF17.7
delete2026-08-27
delete0
PREAI
deleteGuanqiao Li; Michelle L Hermiston
deleteShare
deleteSave
Building stronger blood systems
deleteLancet Haematology
IF17.7
delete2026-08-27
delete0
PREAI
deleteTalha Burki
deleteShare
deleteSave
Beyond maximum grade: key regulatory considerations in adverse event reporting
deleteLancet Haematology
IF17.7
delete2026-08-27
delete0
PREAI
deleteKyriaki Tzogani; Tarec C El-Galaly; Neil Everest; Christian Gisselbrecht; Noriko Mitsuiki; Sumimasa Nagai; Rhianna Thompson; Gita Thanarajasingam
deleteShare
deleteSave
Beyond maximum grade: long-term toxicity and survivorship in haematological malignancies
deleteLancet Haematology
IF17.7
delete2026-08-27
delete0
PREAI
deleteTove Wästerlid; Bryan S Valcarcel; Diana Presno; German Stemmelin; Ananda Plate; Elisavet Syriopoulou; Michael D Stubblefield; Lindsay M Morton; Matthew Matasar; Gita Thanarajasingam; Karin E Smedby
deleteShare
deleteSave